Zagros Pharmed Pars Pharmaceutical Company (DEDAM) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DEDAM
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Report to 1404/12/29 | Report to 1403/12/30 | Report to 1402/12/29 | Report to 1401/12/29 |
|---|---|---|---|---|
| P/E TTM | 8.03 | 6.26 | 7.35 | 20.70 |
| P/S TTM | 2.16 | 1.57 | 2.16 | 4.07 |
| P/B | 3.77 | 2.45 | 2.90 | 8.30 |
| Gross margin TTM | 44.8% | 39.9% | 47.7% | 37.4% |
| Net margin TTM | 26.9% | 25.1% | 29.5% | 19.7% |
| ROA TTM | 18.2% | 16.7% | 17.4% | 12.9% |
| ROE TTM | 46.9% | 39.2% | 39.5% | 40.1% |
| Collection period TTM | 344 days | 350 days | 324 days | 333 days |
| Inventory period TTM | 69 days | 53 days | 69 days | 55 days |
| PEG TTM | 0.21 | - | 0.06 | - |
| PEGY TTM | 0.17 | 0.38 | 0.06 | - |